Volcano, a developer and manufacturer of precision guided therapy tools, has announced the commercial release and initial implantations of its new Crux vena cava filter (VCF) in patients at risk for recurrent pulmonary embolism (PE). It ...
Tags: Volcano, therapy tools
The European Union has granted CE mark approval to BiO2 Medical's inferior vena cava(IVC)filter for use in critically ill patients who are at increased risk of pulmonary embolism and temporarily contraindicated for anticoagulation therapy. ...
Tags: European Union, CE mark approval, BiO2 Medical, IVC filter
Crux Biomedical has obtained the US Food and Drug Administration (FDA) approval for its bi-directional retrieval inferior vena cava filter (VCF), designed to trap blood clots leading to fatal pulmonary embolisms. The helical shape of VCF ...
Tags: Crux Biomedical, vena cava filter, VCF